Rheumatic DiseaseInfo Center
Three Rare Diseases Get New Treatment Option
The US Food and Drug Administration (FDA) has approved a new treatment option for three rare diseases.
Green Light for Biosimilar to Humira
The US Food and Drug Administration has approved its fourth biosimilar.
FDA Approves First Biosimilar Etanercept
The US Food and Drug Administration (FDA) has approved the first biosimilar etanercept.
Are 'Generic' Biologics the Same as the 'Brand'?
Generic versions of often expensive brand-name biologic medications appear safe and effective on the whole, a new study found.
Second Biosimilar Gets FDA Nod
The US Food and Drug Administration (FDA) has approved the second-ever biosimilar, and it's meant to treat multiple conditions that affect the immune system.
Novel Arthritis Rx Shows Promise
It's not yet approved by the US Food and Drug Administration (FDA), but a new refractory rheumatoid arthritis drug has shown potential in a phase III trial.
Experimental Lupus Rx Shows Promise
Lupus is a chronic and often disabling disease with very few treatment options. But there may be some hope on the horizon where that is concerned.
Good News for Rheumatoid Arthritis Treatment
Anti-TNFs are a class of medications often used to treat inflammatory conditions like rheumatoid arthritis (RA). But when an anti-TNF fails, what's the next step?
Could Antibiotics Be Tied to Arthritis in Kids?
Antibiotics are miracle drugs that have saved millions of lives, but some worry that their overuse could have serious consequences. Now there may be yet another cause for concern.
Pregnancy and Lupus: A Fairly Safe Combination?
Many women with lupus have been warned about the possible dangers of becoming pregnant and having the condition. But new evidence suggests that these risks might have been overestimated.